v3.25.2
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)
1 Months Ended 3 Months Ended
Sep. 27, 2024
swap
Sep. 26, 2024
swap
Jun. 15, 2023
swap
Sep. 30, 2022
swap
Jun. 28, 2025
USD ($)
Mar. 29, 2025
USD ($)
Apr. 01, 2024
USD ($)
Sep. 23, 2022
USD ($)
Derivative [Line Items]                
Debt outstanding         $ 1,224,782,000 $ 1,224,788,000    
Number of Interest Rate Swaps Remaining | swap 2              
Level 2 | Convertible Senior Notes Due 2026                
Derivative [Line Items]                
Convertible notes, fair value         289,900,000      
Level 2 | Convertible Senior Notes Due 2029                
Derivative [Line Items]                
Convertible notes, fair value         695,800,000      
Term loan, net of financing fees                
Derivative [Line Items]                
Debt outstanding         $ 238,788,000 240,028,000    
Foreign Exchange Contract                
Derivative [Line Items]                
Percentage of sales generated outside the US         24.60%      
Maturity period for foreign currency contracts         1 year      
Interest Rate Swap                
Derivative [Line Items]                
Number of interest rate swaps entered | swap       4        
Derivative, percentage of notional value of debt 80.00%              
Derivative, blended fixed interest rate 3.31%              
Notional amount         $ 203,195,000     $ 219,800,000
Number Of Interest Rate Swaps Terminated | swap   2 2          
Designated as Hedging Instrument | Foreign Exchange Contract                
Derivative [Line Items]                
Deferred income tax expense (benefit)         0      
Designated as Hedging Instrument | Foreign Exchange Contract                
Derivative [Line Items]                
Designated foreign currency hedge contracts outstanding         14,200,000 23,600,000    
Designated as Hedging Instrument | Cash Flow Hedging                
Derivative [Line Items]                
Gain (loss) to be reclassified within the next twelve months         900,000      
Designated as Hedging Instrument | Interest Rate Swap                
Derivative [Line Items]                
Amount of Gain (Loss) Recognized in AOCL         1,400,000      
Not Designated as Hedging Instrument | Foreign Exchange Contract                
Derivative [Line Items]                
Non-designated foreign currency hedge contracts outstanding         $ 109,600,000 $ 89,600,000    
Attune Medical                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Contingent consideration             $ 25,300,000